Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Verastem, Inc. (VSTM)  
$12.02 0.17 (1.43%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 25,230,000
Market Cap: 303.26(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.8 - $14.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 1,735 21,833 25,311 165,018
Total Sell Value $18,442 $258,319 $292,764 $385,800
Total People Sold 4 4 4 4
Total Sell Transactions 9 20 37 63
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 168
  Page 4 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Stuglik Brian M Chief Executive Officer   •       •      –    2022-01-03 4 S $2.05 $53,368 D/D (26,033) 1,142,666 49%     
   Paterson Dan President and COO   •       –      –    2022-01-03 4 S $2.05 $48,245 D/D (23,534) 480,751 49%     
   Gagnon Robert E. Chief Financial Officer   •       –      –    2022-01-03 4 S $2.05 $40,205 D/D (19,612) 559,289 49%     
   Stuglik Brian M Chief Executive Officer   •       •      –    2021-12-20 4 S $2.27 $31,058 D/D (13,682) 1,168,699 36%     
   Gagnon Robert E. Chief Financial Officer   •       –      –    2021-12-20 4 S $2.27 $12,478 D/D (5,497) 578,901 36%     
   Paterson Dan President and COO   •       –      –    2021-12-20 4 S $2.27 $24,956 D/D (10,994) 504,285 36%     
   Paterson Dan President and COO   •       –      –    2021-12-15 4 A $0.00 $0 D/D 181,500 515,279     -
   Stuglik Brian M Chief Executive Officer   •       •      –    2021-12-15 4 A $0.00 $0 D/D 363,000 1,182,381     -
   Gagnon Robert E. Chief Financial Officer   •       –      –    2021-12-15 4 A $0.00 $0 D/D 148,500 584,398     -
   Stuglik Brian M Chief Executive Officer   •       •      –    2021-11-01 4 D $2.59 $15,123 D/D (5,839) 819,381     -
   Paterson Dan President and COO   •       –      –    2021-08-12 4 D $2.87 $144,200 D/D (50,244) 333,779     -
   Gagnon Robert E. Chief Financial Officer   •       –      –    2021-08-12 4 D $2.87 $130,094 D/D (45,329) 435,898     -
   Stuglik Brian M Chief Executive Officer   •       –      –    2021-03-25 4 A $0.00 $0 D/D 191,828 1,186,185     -
   Neumann Frank Chief Medical Officer   •       –      –    2021-01-06 4 A $0.00 $0 D/D 150,000 150,000     -
   Gagnon Robert E. Chief Financial Officer   •       –      –    2020-12-18 4 A $0.00 $0 D/D 67,925 571,635     -
   Stuglik Brian M Chief Executive Officer   •       –      –    2020-12-18 4 A $0.00 $0 D/D 203,776 994,357     -
   Paterson Dan President and COO   •       –      –    2020-12-18 4 A $0.00 $0 D/D 135,851 555,816     -
   Barberich Timothy J Director   –       •      –    2020-12-04 4 B $2.17 $108,500 D/D 50,000 218,000 2.39 22%     
   Gagnon Robert E. Chief Financial Officer   •       –      –    2020-08-11 4 A $0.00 $0 D/D 290,210 503,710     -
   Stuglik Brian M Chief Executive Officer   •       –      –    2020-08-11 4 A $0.00 $0 D/D 419,581 790,581     -
   Paterson Dan President and COO   •       –      –    2020-08-11 4 A $0.00 $0 D/D 321,679 419,965     -
   Shah Rajeev M. 10% Owner   –       –       •   2020-06-25 4 S $1.91 $2,219,941 I/I (1,161,300) 16,142,051 32%     
   Shah Rajeev M. 10% Owner   –       –       •   2020-04-27 4 S $2.31 $3,002,099 I/I (1,301,300) 17,303,351 45%     
   Gagnon Robert E. Chief Financial Officer   •       –      –    2020-03-27 4 A $0.00 $0 D/D 62,500 213,500     -
   Paterson Dan President and COO   •       –      –    2020-03-27 4 A $0.00 $0 D/D 75,000 98,286     -
  168 Records found
  1  2  3  4  5  6  7   
  Page 4 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us